Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

USNA

USANA HEALTH SCIENCES INC

Medicinal Chemicals & Botanical Products · SIC 2833CIK 896264Held by 3 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2026
$925.0M
Net Income FY2026
$11.0M
EPS (Basic, as reported)
$0.58
Net Margin FY2026
1.2%
ROE FY2026
2.0%
Total Equity
$533.0M
Shares Out
18M
Business description

USANA HEALTH SCIENCES INC — Medicinal Chemicals & Botanical Products. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2010–FY2026; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 790 → 925 +1.8% CAGR
Revenue7901,0061,0471,1891,0611,1351,186921855925
Cost of revenue(141)(180)(179)(201)(188)(209)(218)(177)(161)(201)
Gross profit650759868989873926969744693724
Research & development(5)(6)(9)(10)(10)(11)(11)(11)(12)(11)
Selling, general & administrative(185)(209)(265)(275)(268)(261)(279)(257)(263)(337)
Total operating expenses(534)(617)(735)(800)(727)(749)(798)(651)(627)(687)
Operating income116142133188146176170936637
Interest expense00000(1)000(1)
Interest & investment income112453310112
Other income (expense), net01234109104
Pre-tax income1161431351921501781711027642
Income tax expense(39)(48)(72)(65)(50)(53)(54)(39)(34)(30)
Net income779563126101125117644211
EPS — basic$5.80$7.44$2.57$5.24$4.44$5.89$5.78$3.31$2.20$0.58
EPS — diluted$5.60$7.18$2.53$5.12$4.41$5.86$5.73$3.30$2.19$0.58
Shares outstanding — basic (M)13132424232120191919
Shares outstanding — diluted (M)14132525232120191919

Showing the latest 10 of 14 fiscal years.

  • ⚑ Weighted-average shares changed ×1.85 between FY2016 and FY2017 — likely a stock split. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.